The interventional cardiology devices market is expected to reach USD 20.85 Billion by 2022 from USD 14.52 Billion in 2017, at a CAGR of 7.5%.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548

Factors driving the growth of this market include technological advancements in interventional cardiology devices, rising geriatric population, increasing incidence of cardiovascular diseases, and improving healthcare infrastructure in emerging markets.

Top Key Players

The key players in the interventional cardiology devices market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B. Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and BIOTRONIK (Germany).

Factors such as the high degree of consolidation, the high cost of devices, and complex regulatory framework for the approval of new products may restrain the market’s growth to a certain extent.

The global interventional cardiology devices market is segmented based on type and region.

Based on region, the interventional cardiology devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is estimated to dominate the interventional cardiology devices market in 2017. This is mainly due to factors such as the increasing patient base of cardiovascular diseases, technological advancements in interventional cardiology devices, and growing healthcare expenditures.

interventional cardiology devices market

Read More @ https://www.marketsandmarkets.com/PressReleases/cardiology-devices.asp